SEC-sourced researchBeta

EDIT

Editas Medicine, Inc.

US markets

Data passport

CIK: 0001650664
Exchange: Nasdaq
Business activity: — · SIC 2836
Financial inputs: 6/6
Filing date: Sep 9, 2026
SEC registry record: Operating company

Last updated: Oct 6, 2026, 3:03 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

EDIT · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2024	32,314,000.0000	Mar 9, 2026
December 2025	40,520,000.0000	Mar 9, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	40,520,000.0000	-160,060,000.0000	-165,241,000.0000	186,534,000.0000	159,246,000.0000	Mar 9, 2026
December 2024	32,314,000.0000	-237,093,000.0000	-210,284,000.0000	341,589,000.0000	207,315,000.0000	Mar 9, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$40.52M	December 2025	Mar 9, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$32.31M	December 2024	Mar 9, 2026	10-K
Net incomeNetIncomeLoss	-$160.06M	December 2025	Mar 9, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$165.24M	December 2025	Mar 9, 2026	10-K
Total assetsAssets	$186.53M	December 2025	Mar 9, 2026	10-K
Total liabilitiesLiabilities	$159.25M	December 2025	Mar 9, 2026	10-K

New filings

Explore methodology ↗